Hostname: page-component-cd9895bd7-dk4vv Total loading time: 0 Render date: 2025-01-03T14:42:15.964Z Has data issue: false hasContentIssue false
  • English
  • Français

Serum beta2-microglobulin as a possible early indicator of glomerular filtration impairment in subjects receiving long-term lithium treatment

Published online by Cambridge University Press:  16 April 2020

G Rutigliano  and
F Vadruccio
G Rutigliano
Affiliation:
Center of Psychopharmacotheropy, University of Bari, Psychiatric Clinic-Policlinic, 11 piazza G Cesare, 70124Bari, Italy
F Vadruccio
Affiliation:
Center of Psychopharmacotheropy, University of Bari, Psychiatric Clinic-Policlinic, 11 piazza G Cesare, 70124Bari, Italy
Get access

Summary

Serum β2-microglobulin (β2m) levels were increased in ten out of 52 patients on chronic lithium treatment, while creatinine levels were within the normal range in all of them and creatinine clearance was below the normality in only five. We propose serum β2m assessment as a possible precocious indicator of glomerular filtration impairment, and recommend its frequent determination in patients chronically treated with lithium to prevent the occurrence of renal insufficiency.

Keywords

β2-microgloubulinkidney damagelithium
Type
Short communication
Information
European Psychiatry , Volume 9 , Issue 4 , 1994 , pp. 201 - 203
Copyright
Copyright © European Psychiatric Association 1994

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Aurell, MSvalander, CWallin, LAlling, CRenal function and biopsy findings in patients on long-term lithium treatment. Kidney Int 1981;20:663-8CrossRefGoogle ScholarPubMed
Bataille, RGrenier, JSany, Jet al. β 2-microglobulin in myeloma: optimal use for staging, prognosis and treatment. A prospective study of 160 patients. Blood 1984;63:468-76CrossRefGoogle Scholar
Berggard, IBearn, AGIsolation and properties of a low molecular weight β 2-microglobulin occuring in human biological fluids. J Biol Chem 1968;243:4095-103Google Scholar
Coppen, AStandish-Barry, HBailey, Jet al. Does Lithium reduce the mortality of recurrent mood disorders? J Affect Dis 1991;23:1–7CrossRefGoogle ScholarPubMed
Descos, LAndré, CBeorchia, SSerum levels of β 2-microglobulin. A new marker of activity in Crohn’s disease. N Engl J Med 1979;440-1Google Scholar
Evrin, PEWibell, LSerum β 2-microglobuline in various disorders. Cl Chim Acta 1973;43:183-7CrossRefGoogle Scholar
Gitlin, MJLithium-induced renal insufficiency. J Clin Psychopharmacol 1993;4:276-9Google Scholar
Hällgren, RAlm, POHellsing, KRenal function in patients on Lithium treatment. Br J Psychiatry 1979;135:22-7CrossRefGoogle ScholarPubMed
Karlsson, HAGroth, TSege, KWibell, LPeterson, PATurnover in humans of β 2-m: the costant chain of HLA-antigens. Eur J Clin Invest 1980;10:293–300CrossRefGoogle Scholar
Michaslki, JPDaniels, TETalal, NGrey, HMβ 2-microglobulin and lymphocyte infiltration in Sjögren’s syndrome. N Engl J Med 1975;18:69–74Google Scholar
Peterson, PAEvrin, PHBerggard, IDifferentiation of glomerular, tubular and normal proteinuria, determinations of urinary excretion of β 2-microglobulin, albumin and total protein. J Clin Invest I969;48:1189-98CrossRefGoogle Scholar
Phan, LCoulomb, FBoudon, Met al. Glomerulonephrite induite par le Lithium. Nephrologie 1991;12:185Google Scholar
Revillard, JPβ 2-microglobulin in immunological disorders with special reference to acquired immunodefficiency syndrome. Rev Inst Pasteur Lyon 1985;18:69–74Google Scholar
Roitt, IMII complesso maggiore della Istocompatibilità.In: Roitt, IM, ed. Immunologia: fisiologia, patologica e clinica. Liviana Ed, PD, I I987;43-5Google Scholar
Samiy, AHRosnick, PBEarly identification of renal problems in patients receiving chronic Lithium treatment. Am J Psychiatry 1987;144:670Google ScholarPubMed
Selroos, OBBiochemical markers in sarcoidosis. Crit Rev Clin Lab Sci 1986;24:185–216CrossRefGoogle ScholarPubMed
Simonnet, HGauthier, CVincent, CCompetitive binding of β 2 microglobulin to renal brush-border membrane: affinity measurement, inhibition by serum albumin. Bioch Bioph Acta 1988;940:247-54CrossRefGoogle Scholar
Vincent, CLa β 2-microglobuline: structure, fonction, métabolisme et modifications dans la pathologie Ann Dermatol Veneorol 1990;117:661-8Google Scholar
Weissel, MScherak, OFritzsche, HKolarz, GSerum β 2-microglobulin and SLE. Arthritis Rheum 1976;19:968CrossRefGoogle ScholarPubMed
Zolla-Pazner, SThe use of β 2-microglobulin in the diagnosis of AIDS, suspected AIDS, and preclinical AIDS. Ann NY Acad Sci 1984;437:526-9CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.